Technology

With our proprietary technologies, any instrument can perform optimally with any template. Short or long, fixed or unfixed, single- or double-stranded, DNA or RNA, one of Rubicon’s technologies will make analysis of your clinical samples more sensitive and more reproducible.

Rubicon Technologies

Substantially improves genetic, expression, and epigenetic studies of problematic clinical and research samples such as single cells, plasma/serum, formalin-fixed sections, and immunoprecipitates.

Enables qPCR, microarray, and next-gen sequencing platforms to achieve higher sensitivity, specificity, and robustness.

Has been validated for mutation, genotype, gene and chromosome copy number, expression, sequence, and methylation analyses in research and diagnostic applications.

For more information on the technology that powers our pre-analytical amplification products, please follow the links below:

• PicoPlex WGA for Single Cells
• GenomePlex C-WGA for fixed and other degraded DNA
• TransPlex C-WTA for fixed and other degraded DNA
• PlasmaPlex WGA for plasma, serum, urine
• IP-Plex WGA for sonicated DNA
• MethylPlex WMA for detection and profiling of DNA methylation